Director, Distributor Management

Sorry, this job was removed at 04:23 p.m. (CST) on Thursday, Jan 22, 2026
Easy Apply
Be an Early Applicant
Zug
In-Office
Healthtech • Biotech • Pharmaceutical
The Role

MISSION

Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other individuals who embody our values: care, be real, get it done, and have fun, seriously.


POSTION SUMMARY

Reporting to the Sr Director, International Distributors Management, the incumbent will manage interaction with distributors in Latin America and Middle East in all aspects from Early Access opportunities, commercialization readiness and business performance delivering on established KPIs. This position will be crucial to the International expansion and will be key in driving the commercialization of the company’s international product portfolio. The individual will work closely with cross-functional team across the organization and with distributors in the region.

JOB FUNCTIONS/RESPONSIBILITIES

  • Evaluate and plan new expansion opportunities across existing and future geographical footprint with international product portfolio
  • Ensure alignment of International Commercial Strategy & promotional activity with partners
  • Provide guidance in investment, resource allocation trade-offs to optimize portfolio and ensure alignment with global strategy and future portfolio development
  • Ensure execution of all operational business activities in order to maximize patient access and commercial impact. Manage in-depth business reviews, constant functional support and ad-hoc direct partners interactions on a regular basis as needed.
  • Drive sharing-best-practice initiatives to maximize current business developed by the partners across International Markets including: commercial KPI’s benchmarking, business plan, sales plans and forecasting models, marketing tactics.
  • 30-40% expected international travel requirement (mostly Latin America & Middle East and Africa)

QUALIFICATIONS

Education/Experience:

  • Solid understanding of the pharmaceutical/biotech commercial operations, in multiple healthcare systems, especially in Latin America and Middle East & Africa
  • 10+ years total experience in life sciences (including consulting), biotech or pharma industry, in commercial / business development functions.
  • Proven successful experience in commercial role at international / regional and/or local country level.
  • Experience in managing relationships with external partners / stakeholders in international environment.
  • Hands-on involvement in the development of commercial strategy
  • Good understanding of commercial, market access, IP, regulatory process.
  • Direct work experience in considered territories (Latin America and Middle East & Africa) with ability to communicate in local languages being a distinct advantage
  • Prior “biotech start-up” experience is a distinct advantage
  • Rare or ultra-rare, disease experience preferred.
  • Undergraduate degree required, Top tier MBA and/or relevant post graduate qualifications preferred. Scientific educational background a plus

Knowledge, Skills and Abilities:

  • Able to drive initiatives and lead new projects in a lean organization by working cross functionally and using key stakeholders’ areas of expertise
  • Strong analytical & project management skills
  • Strong cross-cultural understanding and negotiation / communication skills
  • Strong Team Player, highly organized and comfortable managing multiple work streams at once.
  • Exceptional communication and interpersonal skills.
  • Great attention to detail and self-motivation.

 #LI-HYBRID

Mirum Pharmaceuticals is committed to Equal Employment Opportunity (EEO) and to compliance with all Federal, State and Local laws that prohibit employment discrimination on the basis of race, age, national origin, ethnicity, religion, gender, gender identity, pregnancy, marital status, sexual orientation, citizenship, genetic disposition or characteristics, disability, veteran’s status or any other classification protected by applicable State/Federal/Local laws.

Mirum Pharmaceuticals provides reasonable accommodation for qualified individuals with disabilities and disabled veterans in job application procedures.

Similar Jobs

GitLab Logo GitLab

Security Engineer

Cloud • Security • Software • Cybersecurity • Automation
Easy Apply
In-Office or Remote
34 Locations
2500 Employees

CSC Logo CSC

Accountant

Fintech • Legal Tech • Software • Financial Services • Cybersecurity • Data Privacy
In-Office
Zug, CHE
8500 Employees

IMC Trading Logo IMC Trading

Data Engineer

Fintech • Machine Learning • Software • Financial Services
Hybrid
Zug, CHE
1954 Employees

SOPHiA GENETICS Logo SOPHiA GENETICS

BioPharma Business Development (RWD) - Senior Director

Artificial Intelligence • Big Data • Healthtech • Software • Biotech
Remote or Hybrid
Switzerland
450 Employees
144K-247K Annually
Get Personalized Job Insights.
Our AI-powered fit analysis compares your resume with a job listing so you know if your skills & experience align.

The Company
HQ: Foster City, CA
200 Employees
Year Founded: 2018

What We Do

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. Mirum’s approved medication is LIVMARLI® (maralixibat) oral solution which is approved in the U.S. for the treatment of cholestatic pruritus in patients with Alagille syndrome one year of age and older.

Mirum’s late-stage pipeline includes two investigational treatments for debilitating liver diseases affecting children and adults. Maralixibat (LIVMARLI), an oral ileal bile acid transporter (IBAT) inhibitor, is currently being evaluated in clinical trials for pediatric liver diseases and includes the MARCH Phase 3 study for progressive familial intrahepatic cholestasis (PFIC) and the EMBARK Phase 2b study for patients with biliary atresia. In addition, Mirum has an expanded access program open in Canada, Australia, the UK and several countries in Europe for eligible patients with Alagille syndrome.

Mirum has submitted a Marketing Authorization Application to the European Medicines Agency for maralixibat for the treatment of cholestatic liver disease in patients with Alagille syndrome.

Mirum’s second investigational treatment, volixibat, also an oral IBAT inhibitor, is being evaluated in three potentially registrational studies including the OHANA Phase 2b study for pregnant women with intrahepatic cholestasis of pregnancy, VISTAS Phase 2b study for adults with primary sclerosing cholangitis, and the VANTAGE Phase 2b study for primary biliary cholangitis.

Similar Companies Hiring

Camber Thumbnail
Social Impact • Healthtech • Fintech
New York, NY
53 Employees
Sailor Health Thumbnail
Telehealth • Social Impact • Healthtech
New York City, NY
20 Employees
Granted Thumbnail
Mobile • Insurance • Healthtech • Financial Services • Artificial Intelligence
New York, New York
23 Employees

Sign up now Access later

Create Free Account

Please log in or sign up to report this job.

Create Free Account